The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, 213000, China.
Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, 221002, China.
Nutr J. 2024 Nov 30;23(1):151. doi: 10.1186/s12937-024-01059-4.
Multiple Sclerosis (MS), an autoimmune disorder causing demyelination and neurological damage, has been linked to 25-hydroxyvitamin D (25OHD) levels, suggesting its role in immune response and MS onset. This study used GWAS datasets to investigate genetic associations between 25OHD and MS.
We utilized a large-scale prospective cohort to evaluate serum 25OHD levels and MS risk. Linkage Disequilibrium Score Regression (LDSC) assessed genetic correlations between 25OHD levels and MS. Cross-trait genome-wide pleiotropy analysis revealed shared genetic loci. MAGMA analysis identified pleiotropic genes, enriched tissues, and gene sets. Stratified LDSC estimated tissue-specific and cell-specific heritability enrichment, and multi-trait co-localization analysis identified shared immune cell subsets. Bidirectional Mendelian Randomization (MR) assessed the causal association between 25OHD and MS risk.
The observational study found a nonlinear relationship between 25OHD levels and MS risk, with the lowest quartile showing significant risk elevation. Our findings revealed shared genetic structure between 25OHD levels and MS, suggesting a common biological pathway involving immune function and CNS integrity. We found 24 independent loci shared between 25OHD levels and MS risk, enriched in brain tissues and involved in pathways like LDL, HDL, and TG metabolism. Four loci (6p24.3, 6p22.2, 12q14.1, and 19p13.2) had strong co-localization evidence, with mapped genes as potential drug targets. Bidirectional MR analysis supported a causal effect of 25OHD levels on MS risk, suggesting 25OHD supplementation could modulate MS risk.
This study reveals the complex relationship between 25OHD levels and MS, indicating that higher levels are not always advantageous and recommending moderation in supplementation. We identified SMARCA4 as a potential therapeutic target and detailed key pathways influencing this interaction.
多发性硬化症(MS)是一种自身免疫性疾病,会导致脱髓鞘和神经损伤,与 25-羟维生素 D(25OHD)水平有关,提示其在免疫反应和 MS 发病中的作用。本研究使用 GWAS 数据集研究 25OHD 与 MS 之间的遗传关联。
我们利用大型前瞻性队列评估血清 25OHD 水平与 MS 风险。连锁不平衡得分回归(LDSC)评估 25OHD 水平与 MS 之间的遗传相关性。跨性状全基因组多效性分析揭示了共享的遗传位点。MAGMA 分析确定了多效性基因、丰富的组织和基因集。分层 LDSC 估计了组织特异性和细胞特异性遗传率富集,多性状共定位分析确定了共享的免疫细胞亚群。双向孟德尔随机化(MR)评估了 25OHD 与 MS 风险之间的因果关系。
观察性研究发现 25OHD 水平与 MS 风险之间存在非线性关系,最低四分位显示出显著的风险升高。我们的研究结果表明 25OHD 水平和 MS 之间存在共享的遗传结构,表明涉及免疫功能和中枢神经系统完整性的共同生物学途径。我们发现 25OHD 水平和 MS 风险之间有 24 个独立的遗传位点共享,这些位点在脑组织中富集,并参与 LDL、HDL 和 TG 代谢等途径。4 个位点(6p24.3、6p22.2、12q14.1 和 19p13.2)具有强烈的共定位证据,映射基因可能是潜在的药物靶点。双向 MR 分析支持 25OHD 水平对 MS 风险的因果效应,提示 25OHD 补充可能调节 MS 风险。
本研究揭示了 25OHD 水平与 MS 之间的复杂关系,表明较高的水平并不总是有利的,并建议适度补充。我们确定了 SMARCA4 作为一个潜在的治疗靶点,并详细说明了影响这种相互作用的关键途径。